#United States #San Francisco #Vascular Health #Koya Medical #Dayspring treatment

Koya Medical to Present at the J.P. Morgan 2026 Healthcare Conference

Koya Medical, an innovative player in the medtech field, is gearing up to present at the renowned J.P. Morgan Healthcare Conference scheduled for January 14, 2026. Held at the Westin St. Francis Hotel in San Francisco, this event is a pivotal gathering for various stakeholders in the healthcare sector. The company, which specializes in patient-centered solutions particularly within peripheral vascular health, sees this opportunity as a significant platform to discuss its ongoing growth and future endeavors.

What to Expect in the Presentation

CEO Andy Doraiswamy will lead the discussion, focusing on Koya’s remarkable commercial momentum and the impressive growth trajectory of its product line. One key highlight will be the Dayspring® non-pneumatic compression treatment, specifically designed for patients suffering from chronic edema. This innovative treatment stands out for its ability to enhance patient outcomes in a largely underserved aspect of vascular health.

Furthermore, the CEO will share comprehensive insights into the company's clinical research progress related to its development pipeline, demonstrating Koya’s commitment to advancing healthcare solutions based on solid evidence and thorough research. The company's initiatives aim not only to fill treatment gaps but also to elevate overall patient care standards.

The Significance of Vascular Health

Why focus on vascular health, you might ask? In the United States alone, over 35 million people are affected by venous and lymphatic diseases. These conditions can be serious, often going underreported and misunderstood. They significantly affect patients' mobility, quality of life, and long-term health prospects. Koya Medical's mission aligns closely with addressing these challenges, providing scalable, modern solutions that resonate with the urgent need in the healthcare landscape.

Founded in 2018 and based in Dallas, Koya Medical is more than a medtech company; it is a pioneer aiming to reshape how vascular health is perceived and treated. With products designed to cover the entire care continuum—from clinical settings to patients' homes—their approach is refreshingly holistic. The ethos behind Koya stems from a profound personal journey that ignited a passion for bridging the treatment gaps that exist in vascular health.

A Call to Action for Healthcare Stakeholders

As Koya prepares for the J.P. Morgan Healthcare Conference, it invites healthcare professionals, investors, and industry experts to engage with their vision of enhanced patient care. Through innovative solutions such as Dayspring® and ongoing clinical studies, Koya is poised not only to make a mark in medtech but also to foster a dialogue about the importance of comprehensive care in vascular health.

For more information, visit www.koyamedical.com and connect with Koya on LinkedIn.

In conclusion, Koya Medical's presence at the J.P. Morgan Healthcare Conference will undoubtedly stir conversations about the future of vascular health and innovative solutions that can redefine patient care. 2026 promises to be a pivotal year for the company—a year in which it hopes to bring about meaningful changes in the lives of millions suffering from vascular ailments.